You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Glucagon-like peptide-1 (GLP-1) agonists

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists

Not yet recruiting
  • Gastric Ultrasound
  • +2 more
  • Gastric Ultrasound Exam
  • (no location specified)
Aug 15, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

Glucagon-like Peptide 1 Receptor Agonists and Mental Health

Not yet recruiting
  • Diabetes Mellitus
  • +2 more
  • GLP-1 receptor agonist
  • (no location specified)
Aug 4, 2022

Effects of GLP-1 Agonists on Gastric Volume

Not yet recruiting
  • Diabetes
  • +3 more
  • Gastric Ultrasound
  • Charleston, South Carolina
    Medical University of South Carolina
May 10, 2023

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • Myocardial Infarction
  • PCI
  • Naples, Italy
    Celestino Sardu
Aug 31, 2023

A Pan-European Post-Authorisation Safety Study: Risk of

Not yet recruiting
  • Pancreatic Cancer
  • Exenatide
  • Non-GLP-1 RA based glucose lowering drugs
  • (no location specified)
Dec 21, 2022

Anti-obesity Pharmacotherapy and Inflammation

Not yet recruiting
  • Obesity
  • Liraglutide or Semaglutide
  • Phentermine-Topiramate combination
  • New Orleans, Louisiana
  • +1 more
Mar 3, 2023

Chronic Kidney Diseases Trial in Nashville (dulaglutide injection)

Recruiting
  • Chronic Kidney Diseases
  • dulaglutide injection
  • Nashville, Tennessee
    Vanderbilt University Medical Center
Mar 20, 2022

Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

Not yet recruiting
  • Overweight and Obesity
  • 24-hour ambulatory blood pressure
  • Liberal salt diet
  • (no location specified)
Oct 4, 2023

Type 2 Diabetes, Coronary Artery Disease Trial in Athens (Liraglutide, Metformin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Coronary Artery Disease
  • Athens, Attiki, Greece
    ''Attikon'' University General Hospital
Mar 3, 2021

Morbid Obesity, Metabolic Syndrome, Diabetes Trial in Columbia (GLP-1 receptor agonist)

Not yet recruiting
  • Morbid Obesity
  • +4 more
  • GLP-1 receptor agonist
  • Columbia, Missouri
    University of Missouri Hospital
Nov 20, 2023

Delayed Gastric Emptying, Gastroparesis Trial in Chapel Hill (gastric ultrasound)

Not yet recruiting
  • Delayed Gastric Emptying
  • Gastroparesis
  • gastric ultrasound
  • Chapel Hill, North Carolina
    University of North Carolina Medical Center
Sep 8, 2023

Stroke, Stroke, Acute, Stroke, Ischemic Trial in Linyi, Hong Kong (Semaglutide)

Recruiting
  • Stroke
  • +3 more
  • Linyi, Shangdong, China
  • +1 more
Jun 24, 2023

Effects of Glucagon-like-Peptide-1 Analogues on Sexuality

Recruiting
  • Sexual Desire
    • Basel, Switzerland
      University Hospital Basel, Endocrinology, Diabetes and Metabolis
    Nov 28, 2022

    Non-Alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 Diabetes Trial in Al Ain (GIP/GLP-1a)

    Not yet recruiting
    • Non-Alcoholic Fatty Liver Disease
    • +3 more
    • Al Ain, Abu Dhabi, United Arab Emirates
      Internal Medicine, College of Medicine and Health Sciences
    Mar 1, 2023

    Type II Diabetes Trial in Dijon (drug, procedure, other)

    Recruiting
    • Type II Diabetes
    • GLP-1 agonists
    • +2 more
    • Dijon, France
      Chu Dijon Bourgogne
    Jan 2, 2023

    Ischemic Stroke Trial in Herlev (Byetta, Normosaline)

    Recruiting
    • Ischemic Stroke
    • Herlev, Denmark
      Department of Neurology, Herlev-Gentofte Hospital
    Nov 13, 2021

    Type1 Diabetes Trial in Baltimore (Glucagon-like peptide-1, Placebos)

    Recruiting
    • Type1 Diabetes Mellitus
    • Glucagon-like peptide-1
    • Placebos
    • Baltimore, Maryland
      University of Maryland
    Apr 8, 2022

    GLP-1 Receptor Agonists on Efficacy and Persistence, Adherence

    Completed
    • Type 2 Diabetes
    • Obesity
    • Valencia, Spain
      INCLIVA
    Sep 6, 2022

    Osteoporosis, Postmenopausal, Diabetes, Type 2 Trial in Jackson (GLP-1 receptor agonist)

    Recruiting
    • Osteoporosis, Postmenopausal
    • Diabetes Mellitus, Type 2
    • GLP-1 receptor agonist
    • Jackson, Mississippi
      University of Mississippi Medical Center
    Aug 5, 2022

    Cardiovascular Diseases Trial in Cambridge (Saline 0.9%, Glucagon (25ng/kg/min), Glucagon (50ng/kg/min))

    Recruiting
    • Cardiovascular Diseases
    • Saline 0.9%
    • +3 more
    • Cambridge, Cambridgeshire, United Kingdom
      Addenbrooke's Hospital
    Dec 10, 2021

    Type 2 Diabetes Trial in Xuzhou (GLP-1 receptor agonist)

    Recruiting
    • Type 2 Diabetes Mellitus
    • GLP-1 receptor agonist
    • Xuzhou, Jiangsu, China
      Department of Endocrinology
    Apr 16, 2022

    Retrospective Data of Glucagon-like Peptide-1 Participanta With

    Recruiting
    • Diabetes Mellitus, Type 2
    • Skopje, North Macedonia
      Novo Nordisk Investigational Site
    Jul 22, 2022

    Obesity Trial in Mansourah, Mansoura (Liraglutide)

    Recruiting
    • Obesity
    • Mansourah, Dakhlia, Egypt
    • +1 more
    Feb 24, 2022